Audit is important part of drug safety and regulation

BMJ 2005; 331 doi: https://doi.org/10.1136/bmj.331.7514.456 (Published 18 August 2005) Cite this as: BMJ 2005;331:456
  1. Michael I Carter, consultant anaesthetist (Michael.Carter@ldh-tr.anglox.nhs.uk),
  2. Jane Murkin, patient safety manager
  1. Luton and Dunstable Hospital NHS Trust, Luton LU4 0DZ
  2. Luton and Dunstable Hospital NHS Trust, Luton LU4 0DZ

    EDITOR—Waller et al write about the responsibilities of the pharmaceutical companies and the regulating agencies such as the UK Medicines and Healthcare products Regulatory Agency to improve the safety of the drugs that are licensed for prescription.1 Although cyclo-oxygenase 2 inhibitors and selective serotonin reuptake inhibitors have been under the spotlight in recent months, other drugs may be of greater concern.

    In …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial